6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione | CAS 64845-67-6

Element: naphthacenedione trihydroxy methoxy

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » trihydroxy-methoxy-naphthacenedione-PX253180

Identification

6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione

CAS:

64845-67-6

EINECS:

Molecular Formula:

C₁₉H₁₂O₆

MDL:

Synonym:

doxorubicin impurity 2 ; 6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione ; 7,8-dehydro-9,10-desacetyldoxorubicinone ; 6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione (doxorubicin impurity)

Suppliers

Get Quick Quote

CAS equal suppliers

Doxorubicin Impurity 2

Aozeal Certified Standards (AOCS), Inc.

D0057.05

Prices & Availability

Data is processed

Properties for 6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione

Molecular Weight:

336.29498 g·mol−1

Safety & Transport Information

coming up soon

Alternative Distributors of [6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione]

Producers or manufacturers change the product range from time to time. The following companies
have appeared as suppliers in the past / currently not verified

Clearsynth Canada INC.

Downloads

Mol File:

-/-

MSDS:

-/-

Related products

View related products

5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-

(8S-cis)-8-Acetyl-10-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione

5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-

5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-

5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-

5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,(8S,10S)-

5,12-Naphthacenedione,8-acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-,hydrochloride (1:1), (8S,10S)-

5,12-Naphthacenedione,10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,(8S,10S)-

(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide(>85%)(Doxorubicin Imp